Loading...
Country's Decision or any other Communication (DEC)
  |  
BCH-DEC-BR-299613-1   |   PDF   |   Print   |  
last updated: 25 Jun 2026
Amendment
No
General Information
Commercial Release (Import and Commercialization) Poulvac® Procerta HVT-IBD - Technical Opinion 7666/2021.
EN
02 Sep 2021
No
Subject of the decision, notification, communication or declaration
  • Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
  • Decision on LMOs for direct use as food or feed, or for processing (Article 11, LMOs-FFP)
LMOs for intentional introduction into the environment
No
Yes
Yes
Yes
Yes
LMOs for direct use as food or feed, or for processing (LMOs-FFP)
  • LMOs for processing
No
Result of the decision
Approval of the import and/or use of the LMO(s) without conditions
Information sharing with other databases
Yes
Yes
Yes
Yes
LMO identification & risk assessment
  • BCH-LMO-SCBD-105260-1 Living Modified Organism VECTORMUNE® HVT-IBD
    Ceva Saúde Animal Ltda(CEVA) | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
  • BCH-RA-BR-299521-1 Risk Assessment generated by a regulatory process Risk assessment Poulvac® Procerta HVT-IBD - Technical Opinion 7666/2021.
    VECTORMUNE® HVT-IBD | Turkey herpesvirus, Meleagrid herpesvirus 1, Production of medical or pharmaceutical compounds (human or animal)
Document on the decision, communication, notification or declaration